venous thromboembolism

de Felice, Elisabeth
July 2013
New Zealand Doctor;7/31/2013, p33
The article focuses on the treatment of venous thromboembolism (VTE) among men and women. It states that three factors have been the key for VTE development such as blood coagulation, vein damage, and venous stasis. It mentions that the American College of Physicians and American Academy of Family Physicians have formulated guidelines for VTE diagnosis. It adds that low molecular weight heparins (LMWH) and warfarin are the recommended treatment for VTE.


Related Articles

  • ACP guideline on oral therapy for T2DM.  // PharmacoEconomics & Outcomes News;3/3/2012, Issue 648, p2 

    The article focuses on the development by the American College of Physicians (ACP) of a clinical practice guideline on the use of oral drug therapy for patients with type 2 diabetes mellitus.

  • Guidelines discourage routine use of heparin prophylaxis in hospitals. Garrett, Anna D. // Drug Topics;Jan2012, Vol. 156 Issue 1, p35 

    The article focuses on the guidelines from the American College of Physicians which recommends against the routine use of heparin prophylaxis in preventing venous thromboembolism in hospitalized patients in the U.S. It is noted that the guideline is based on the meta-analysis of 40 trials that...

  • LMWH preferred to heparin for DVT, according to new ACP/AAFP guideline. Meszaros, Liz // Geriatrics;Jul2007, Vol. 62 Issue 7, p34 

    The article discusses a guideline issued by the American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) concerning the treatment of venous thromboembolism (VTE). According to the guideline, low molecular weight heparin (LMWH) as treatment for deep venous...

  • Percutaneous venous interventions. Bravo, S.M.; Reinhart, R.D.; Meyerovitz, M.F. // Vascular Medicine;1998, Vol. 3 Issue 1, p61 

    Percutaneous procedures by interventional radiologists are becoming an increasingly frequent part of the overall care of patients with complex venous thrombotic diseases. Inferior vena caval filters are used in the setting of failed or contraindicated anticoagulation. Catheter-directed...

  • Recurrent Venous Thromboembolism in a Patient with Heterozygous Factor V Leiden Mutation. White, C. Whitney; Thomason, Angela R.; Prince, Valerie // Hospital Pharmacy;Sep2014, Vol. 49 Issue 8, p748 

    Objective: To report a patient case identifying risk for recurrent venous thromboembolism (VTE) associated with heterozygous Factor V Leiden mutation. Case Summary: A 54-year-old Caucasian male was diagnosed with heterozygous Factor V Leiden mutation in 2008 after experiencing a deep vein...

  • Still Don't Believe Organized Medicine Wants CONTROL of Health Care?  // Texas Journal of Chiropractic;11/1/2013, p7 

    The article discusses the position of the American College of Physicians (ACP) on the role of advanced nurse personnel in clinical teams. According to the ACP, healthcare delivery systems should be changed in order to meet the demands of the patients. The position of the American Academy of...

  • Clinical Review of Vascular Surgery: Venous Disease. Peterson, David; Mowatt-Larssen, Eric // Journal of Surgical Radiology;Oct2011, Vol. 2 Issue 4, p438 

    The article presents information on venous thromboembolism (VTE), a disease developed due to disturbances in regulation of blood coagulation causing significant patient morbidity and mortality in U.S. It further provides the clinical scores of the pathological conditions associated with VTE...

  • thrombophlebitis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2314 

    A definition of the term "thrombophlebitis" is presented. It refers to inflammation of a vein in conjunction with the formation of a thrombus. The inflammation frequently occurs in the leg. Drugs used to treat thrombophlebitis include heparins or warfarin. Factors that need to consider in...

  • Warfarin Overdose: A 25-Year Experience. Levine, Michael; Pizon, Anthony; Padilla-Jones, Angela; Ruha, Anne-Michelle // Journal of Medical Toxicology;Jun2014, Vol. 10 Issue 2, p156 

    Warfarin, a vitamin K antagonist, is widely used for the prophylaxis and treatment of thromboembolic disease. While guidelines exist for management of a supratherapeutic international normalized ratio following therapeutic warfarin use, these guidelines are not designed for management of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics